CLINICAL TRIALS

Advancement of clinical and microbiological research for diagnosis and treatment effects.

LABORATORY SERVICES

Standardised clinical trial services in pre-analytical, analytical and post-analytical procedures.

DATA MANAGEMENT

Initiation and deployment of clinical trials data base management systems.

GOOD CLINICAL PRACTICE

Accredited theory based modules with practical training for clinicians and support staff.

Welcome to TASK!

About Us

TASK Applied Science (TASK) is a clinical research organisation in Cape Town, South Africa with a focus on performing clinical trials in tuberculosis (TB). TASK provides assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis, as well as for other prevalent diseases such as asthma, osteoarthritis and vaccine studies, where new and improved treatments are urgently needed.

The company was founded in 2005 by Prof. Andreas Diacon to accelerate the development and evaluation of novel anti-tuberculosis drugs. TASK mainly collaborates with international NGOs, government funded consortia, academic centers and pharmaceutical companies on various drug development projects.

TASK now employs over 150 staff members, has invested in state of the art bio-safety level 3 laboratory capacity as well as a network of clinical sites in Cape Town and the Western Cape.

 

Vision and Mission

Better healthcare starts with us. TASK provides a platform for the development of novelties in healthcare that benefit the community.

Values

We want to be excellent. Do our work right and on time, every time. We own up, learn, and improve each day. We are TASK.

Resources

The Western Cape is among the areas with the highest Tuberculosis cases worldwide and we have years of experience in Tuberculosis  Research.

We believe in community

COMMUNITY ENGAGEMENT PROJECTS
  • Kids In Action

    The focus was to encourage adults in the community to seek knowledge.

  • Delft WIFI

    TASK is one of the Main Sponsors for the DELFT PUBLIC WIFI Project.

Current Treatment Stand

Furthermore, TB is increasingly becoming resistant to the current treatment

New TB Drugs In The Pipeline

There are currently at least 12 drugs in various stages of clinical evaluation for TB

Clinical Studies

We do many clinical studies, click to read more about it.

Asthma Trials

We are looking for children and adults to participate.

TB Research

Tuberculosis is one of the major causes of disability and death worldwide.

TB RESEARCH

Tuberculosis is one of the major causes of disability and death worldwide.
TB is currently the leading cause of death from a single infectious agent (above HIV/AIDS). In 2017, TB caused an estimated 1.6 million deaths worldwide. In the same year an estimated 10.0 million people developed TB globally (WHO Global TB report, 2018). South Africa remains one of the World Health Organization’s 30 high TB-burden countries contributing 3% to the global TB burden, with close to 800 people out of every 100 000 of the country’s population developing a new case of TB yearly (South African Health Review, 2018).
TB is a leading cause of death for people infected with HIV.
In 2015, 1 in 3 HIV deaths was due to TB. Globally in 2014, an estimated 480, 000 people developed multidrug-resistant TB (MDR-TB).
TASK is part of the global research community that is committed to finding new ways to better understand, diagnose, treat, and ultimately prevent TB.

RECENT NEWS & EVENTS

TASK hosts Researchers from Tanzania

Recently we hosted Dr Nyanda Elias Ntinginya from NIMR – Mbeya Medical Research Centre, Tanzania and Dr Stellah Mpagama from Kilimanjaro Christian Medical Centre Moshi, Tanzania. They traveled to TASK in an effort to discuss opportunities for future collaboration between the organisations. They are pictured here in TASK’s canteen with Duncan McDonald, Dr Elana Van…

Read more

GCP International course

Recently TASK Academy, a specific group of staff within the larger company focused on training and skills development, presented on “Implementing Good Clinical Practice at the (trial) site”. This during the kick-off meeting of the European-Latin American TB research collaboration network (EUSAT-RCS), held at the Radboud university medical centre, Nijmegen, the Kingdom of the Netherlands.…

Read more